Russell Frank Company’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Russell Frank Company’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$17K	Hold	14	–	–	﹤0.01%	2941
2015 Q4	$18K	Hold	14	–	–	﹤0.01%	2953
2015 Q3	$20K	Buy	+14	New	+$27K	﹤0.01%	2964
2015 Q2	–	Sell	-49	Closed	-$146K	–	3095
2015 Q1	$146K	Buy	49 +27	+123%	+$86.4K	﹤0.01%	2699
2014 Q4	$74K	Buy	+22	New	+$77.9K	﹤0.01%	2765
2013 Q4	–	Sell	-2	Closed	-$8K	–	3116
2013 Q3	$8K	Hold	2	–	–	﹤0.01%	3294
2013 Q2	$15K	Buy	+2	New	+$22.2K	﹤0.01%	3037

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

SAIG

Semper Augustus Investments Group Highlands Ranch, Colorado $837M AUM 42.35% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Russell Frank Company's FRTX Position: Q1 2016 in Review

Russell Frank Company held its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) position steady in Q1 2016 at 14 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #2941.

Russell Frank Company first reported a position in FRTX in Q2 2013 and has held it in 7 quarters since. The position peaked at $146K in Q1 2015. 43 funds tracked by Wall St. Rank hold FRTX as of Q1 2016.

Russell Frank Company held 14 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $17K as of Q1 2016.
Russell Frank Company left its Fresh Tracks Therapeutics, Inc. Common Stock share count unchanged in Q1 2016.
Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2941 holding.
Russell Frank Company first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and has held it in 7 quarters since.
Russell Frank Company's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $146K in Q1 2015.
43 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.